|
|
 |
|
Viewing report
|
|
|
|
Prevention of Coronary Heart Disease - Promoting Healthy Lifestyles
Datamonitor, July 2005, Pages: 39
Introduction
Coronary heart disease is the most common cause of death in Europe and the US, at a rate of one in five. However, the majority of coronary events can be prevented by education about risk factors, lifestyle changes and drug therapy. The increasing prevalence of metabolic syndrome, which is a cluster of risk factors in one individual, is associated with a two-fold increase in cardiovascular disease.
Scope
Examines atherosclerosis epidemiology, mortality statistics and the burden it places on healthcare spending
Identifies the risk factors which can be changed or treated to reduce the risk of atherosclerotic disease
Explores risk factor screening, global risk estimation and risk intervention measures including therapeutic lifestyle changes and drug therapy
Recognizes the significance of multiple risk factors present in one individual as metabolic syndrome, leading to coronary heart disease
Highlights
Cardiovascular disease is the leading cause of mortality in the US and Europe with more than one in five deaths from coronary heart disease. Also, the cost of coronary heart disease is huge -the American Heart Association estimates costs of $142 billion in 2005 and the British Heart Foundation estimates it costs the UK almost $14 billion per year.
The majority of heart disease is potentially preventable through continued education and identification of risk factors to prevent the onset of cardiovascular disease leading to heart attack or stroke. Guidelines promote a healthy diet, weight loss and exercise, although drug therapy is recommended where lifestyle changes are insufficient.
Metabolic syndrome is characterized by a cluster of risk factors in one individual. Central obesity and insulin resistance are considered important causative factors. This combination leads to a high risk of type 2 diabetes and cardiovascular disease with an increase in risk of between 1.5 and 2 times.
Reasons to Purchase
Examine the epidemiology of coronary heart disease to identify future patient potential and new market opportunities
Align your product portfolio to the key risk factors associated with coronary heart disease and target the most lucrative markets
Explore current treatment practices and the extent to which unmet needs are not met in order to target additional gaps in the market
Customers who bought this item also bought
Diabetes, Metabolic Syndrome and Cardiovascular Disease
Cardiovascular and Circulatory System - Atherosclerosis or Coronary Artery Disease Drug Pipeline Report
Atherosclerosis or Coronary Artery Disease Therapy Area Pipeline Report
Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery Disease
The Metabolic Syndrome
Coronary Stents - Global Strategic Business Report
Disease and Therapy Review: Heart Failure
Future Approaches in Coronary Artery Disease
Innovations in Cardiovascular Disease Management: Latest Surgical Procedures, Drugs and Medical Devices
Stakeholder Insight: Heart Failure - Pumping Up Therapy Will Prevent Failure
Risk Stratification in the Diagnosis of Cardiovascular Disease
Management of Acute Coronary Syndromes
|
|
|
|
